Leucine aminopeptidase LyLAP enables lysosomal degradation of membrane proteins

Breakdown of every transmembrane protein trafficked to lysosomes requires proteolysis of their hydrophobic helical transmembrane domains. Combining lysosomal proteomics with functional genomic datasets, we identified lysosomal leucine aminopeptidase (LyLAP; formerly phospholipase B domain-containing 1) as the hydrolase most tightly associated with elevated endocytosis. Untargeted metabolomics and biochemical reconstitution demonstrated that LyLAP is a processive monoaminopeptidase with preference for amino-terminal leucine. This activity was necessary and sufficient for the breakdown of hydrophobic transmembrane domains. LyLAP was up-regulated in pancreatic ductal adenocarcinoma (PDA), which relies on macropinocytosis for nutrient uptake. In PDA cells, LyLAP ablation led to the buildup of undigested hydrophobic peptides, lysosomal membrane damage, and growth inhibition. Thus, LyLAP enables lysosomal degradation of membrane proteins and protects lysosomal integrity in highly endocytic cancer cells.

Authors

Institutions

Publication Details

Journal
Science
Published
2025-03-27
DOI
https://doi.org/10.1126/science.adq8331
Citations
6
Primary Topic
Cellular transport and secretion
Type
article
Field-Weighted Citation Impact
6.91
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Leucine aminopeptidase LyLAP enables lysosomal degradation of membrane proteins

Aakriti Jain, Guido T. Bommer, Grace A. Hernandez, James A. Olzmann et al.
6 citations
Science
Cellular transport and secretion
6.91
article

Leucine aminopeptidase LyLAP enables lysosomal degradation of membrane proteins

Aakriti Jain, Guido T. Bommer, Grace A. Hernandez, James A. Olzmann, Rushika M. Perera, Teresa von Linde, Peter J. Rohweder, Tyler C. Detomasi, Roberto Zoncu, Zuopeng Zhang, Isaac P. Heremans, David W. Dawson, Gilles Rademaker, Martina Spacci, Y. Rose Citron, Charles S. Craik, David J. Anderson, Jiayi Luo, Mike Lange, Soma Sen Gupta
article en
6 citations

Abstract

Breakdown of every transmembrane protein trafficked to lysosomes requires proteolysis of their hydrophobic helical transmembrane domains. Combining lysosomal proteomics with functional genomic datasets, we identified lysosomal leucine aminopeptidase (LyLAP; formerly phospholipase B domain-containing 1) as the hydrolase most tightly associated with elevated endocytosis. Untargeted metabolomics and biochemical reconstitution demonstrated that LyLAP is a processive monoaminopeptidase with preference for amino-terminal leucine. This activity was necessary and sufficient for the breakdown of hydrophobic transmembrane domains. LyLAP was up-regulated in pancreatic ductal adenocarcinoma (PDA), which relies on macropinocytosis for nutrient uptake. In PDA cells, LyLAP ablation led to the buildup of undigested hydrophobic peptides, lysosomal membrane damage, and growth inhibition. Thus, LyLAP enables lysosomal degradation of membrane proteins and protects lysosomal integrity in highly endocytic cancer cells.

ScienceVol. 387(6741)
University of California, Los Angeles (US), University of California, San Francisco (US), de Duve Institute (BE), UCSF Helen Diller Family Comprehensive Cancer Center (US), University of California, Berkeley (US)
Openalex Percentile: Top 3%
Cellular transport and secretion
6.91
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.